Scientific and regulatory challenges in evaluating clinical trial protocols for HIV-1/AIDS vaccines - A review from a regulatory perspective (Q26770839)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Scientific and regulatory challenges in evaluating clinical trial protocols for HIV-1/AIDS vaccines - A review from a regulatory perspective	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26732973%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Scientific and regulatory challenges in evaluating clinical trial protocols for HIV-1/AIDS vaccines - A review from a regulatory perspective (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26732973%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26732973%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26732973%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

author name string

TieQun Zhou

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26732973%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

language of work or name

0 references

publication date

28 December 2015

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26732973%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26732973%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

44

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26732973%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26732973%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

90-110

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26732973%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Current advances and challenges in HIV-1 vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOLOGICALS.2015.11.003

7 January 2021

based on heuristic

inferred from DOI database lookup

Homotypic antibody responses to fresh clinical isolates of human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOLOGICALS.2015.11.003

7 January 2021

based on heuristic

inferred from DOI database lookup

NYVAC: a highly attenuated strain of vaccinia virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOLOGICALS.2015.11.003

7 January 2021

based on heuristic

inferred from DOI database lookup

EV02: a Phase I trial to compare the safety and immunogenicity of HIV DNA-C prime-NYVAC-C boost to NYVAC-C alone

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOLOGICALS.2015.11.003

7 January 2021

based on heuristic

inferred from DOI database lookup

EV01: a phase I trial in healthy HIV negative volunteers to evaluate a clade C HIV vaccine, NYVAC-C undertaken by the EuroVacc Consortium.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOLOGICALS.2015.11.003

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant Modified Vaccinia Ankara (MVA) effectively boosts DNA-primed HIV-specific immune responses in humans despite pre-existing vaccinia immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOLOGICALS.2015.11.003

7 January 2021

based on heuristic

inferred from DOI database lookup

Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: a review

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOLOGICALS.2015.11.003

7 January 2021

based on heuristic

inferred from DOI database lookup

Broad and potent immune responses to a low dose intradermal HIV-1 DNA boosted with HIV-1 recombinant MVA among healthy adults in Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOLOGICALS.2015.11.003

7 January 2021

based on heuristic

inferred from DOI database lookup

The end or the beginning of the drive to an HIV-preventive vaccine: a view from over 20 years

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOLOGICALS.2015.11.003

7 January 2021

based on heuristic

inferred from DOI database lookup

Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOLOGICALS.2015.11.003

7 January 2021

based on heuristic

inferred from DOI database lookup

Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOLOGICALS.2015.11.003

7 January 2021

based on heuristic

inferred from DOI database lookup

Immune-correlates analysis of an HIV-1 vaccine efficacy trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOLOGICALS.2015.11.003

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOLOGICALS.2015.11.003

7 January 2021

based on heuristic

inferred from DOI database lookup

An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOLOGICALS.2015.11.003

7 January 2021

based on heuristic

inferred from DOI database lookup

Broad immunogenicity of a multigene, multiclade HIV-1 DNA vaccine boosted with heterologous HIV-1 recombinant modified vaccinia virus Ankara

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOLOGICALS.2015.11.003

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase 1 safety and immunogenicity testing of DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOLOGICALS.2015.11.003

7 January 2021

based on heuristic

inferred from DOI database lookup

Statistical interpretation of the RV144 HIV vaccine efficacy trial in Thailand: a case study for statistical issues in efficacy trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOLOGICALS.2015.11.003

7 January 2021

based on heuristic

inferred from DOI database lookup

First-in-human evaluation of the safety and immunogenicity of a recombinant adenovirus serotype 26 HIV-1 Env vaccine (IPCAVD 001)

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOLOGICALS.2015.11.003

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of humoral and cellular immune responses elicited by a recombinant adenovirus serotype 26 HIV-1 Env vaccine in healthy adults (IPCAVD 001).

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOLOGICALS.2015.11.003

7 January 2021

based on heuristic

inferred from DOI database lookup

Specificity and 6-month durability of immune responses induced by DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOLOGICALS.2015.11.003

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of HIV-1-specific mucosal immune responses following intramuscular recombinant adenovirus serotype 26 HIV-1 vaccination of humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOLOGICALS.2015.11.003

7 January 2021

based on heuristic

inferred from DOI database lookup

First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Vesicular Stomatitis Virus Human Immunodeficiency Virus-1 gag Vaccine (HVTN 090).

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOLOGICALS.2015.11.003

7 January 2021

based on heuristic

inferred from DOI database lookup

Public health considerations for the use of a first generation HIV vaccine. Report from a WHO-UNAIDS-CDC consultation, Geneva, 20-21 November 2002

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOLOGICALS.2015.11.003

7 January 2021

based on heuristic

inferred from DOI database lookup

Gender, age, and ethnicity in HIV vaccine-related research and clinical trials: report from a WHO-UNAIDS consultation, 26-28 August 2004. Lausanne, Switzerland

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOLOGICALS.2015.11.003

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibody responses in primary HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOLOGICALS.2015.11.003

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV vaccine development at the turn of the 21st century

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOLOGICALS.2015.11.003

7 January 2021

based on heuristic

inferred from DOI database lookup

Novel directions in HIV-1 vaccines revealed from clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOLOGICALS.2015.11.003

7 January 2021

based on heuristic

inferred from DOI database lookup

The evolution of HIV-1 and the origin of AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOLOGICALS.2015.11.003

7 January 2021

based on heuristic

inferred from DOI database lookup

Human immunodeficiency virus vaccine trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOLOGICALS.2015.11.003

7 January 2021

based on heuristic

inferred from DOI database lookup

Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOLOGICALS.2015.11.003

7 January 2021

based on heuristic

inferred from DOI database lookup

Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOLOGICALS.2015.11.003

7 January 2021

based on heuristic

inferred from DOI database lookup

Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOLOGICALS.2015.11.003

7 January 2021

based on heuristic

inferred from DOI database lookup

Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOLOGICALS.2015.11.003

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonneutralizing functional antibodies: a new "old" paradigm for HIV vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOLOGICALS.2015.11.003

7 January 2021

based on heuristic

inferred from DOI database lookup

Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOLOGICALS.2015.11.003

7 January 2021

based on heuristic

inferred from DOI database lookup

Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOLOGICALS.2015.11.003

7 January 2021

based on heuristic

inferred from DOI database lookup

Lessons from the RV144 Thai phase III HIV-1 vaccine trial and the search for correlates of protection

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOLOGICALS.2015.11.003

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV-specific humoral responses benefit from stronger prime in phase Ib clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOLOGICALS.2015.11.003

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOLOGICALS.2015.11.003

7 January 2021

based on heuristic

inferred from DOI database lookup

Development of prophylactic vaccines against HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOLOGICALS.2015.11.003

7 January 2021

based on heuristic

inferred from DOI database lookup

Priming with a simplified intradermal HIV-1 DNA vaccine regimen followed by boosting with recombinant HIV-1 MVA vaccine is safe and immunogenic: a phase IIa randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOLOGICALS.2015.11.003

7 January 2021

based on heuristic

inferred from DOI database lookup

Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOLOGICALS.2015.11.003

7 January 2021

based on heuristic

inferred from DOI database lookup

Whole genome deep sequencing of HIV-1 reveals the impact of early minor variants upon immune recognition during acute infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOLOGICALS.2015.11.003

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV-1 Vaccine Trials: Evolving Concepts and Designs

1 reference

https://api.crossref.org/works/10.1016%2FJ.BIOLOGICALS.2015.11.003

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q26770839&oldid=1475665831"